The purpose of this study is to examine the safety and efficacy of Depakote ER in bipolar
depression and to evaluate metabolic and GABA changes with Depakote ER administration using
PET and MRI/MRS brain imaging techniques.
Phase:
Phase 4
Details
Lead Sponsor:
Stanford University
Collaborators:
Abbott National Alliance for Research on Schizophrenia and Depression